Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Oxford's COVID-19 research receives government funding

The three projects include work on an effective vaccine, enabling pre-clinical and clinical vaccine trials, as well as supporting researchers to develop manufacturing processes to produce a vaccine at a million-dose scale.

Another project will examine how existing treatments could be repurposed to treat coronavirus: Professor Sarah Gilbert, £2.2 million for vaccine development and trials; Professor Peter Horby - £2.1 million for research into the effectiveness of current drugs on COVID-19 and Dr Sandy Douglas – £0.4 million, research into vaccine manufacturing capabilities.

The full article is available from the University of Oxford's Website

Similar stories

Professor Sir Nicholas White OBE KCMG FRS

The University of Oxford and the Nuffield Department of Medicine greatly mourn the death of Professor Sir Nicholas White, a distinguished clinician and scientist who was internationally recognised as the leading figure in improving the treatment of malaria worldwide, and whose work has made a lasting contribution to global health research - saving millions of lives worldwide. Our thoughts are with his family at this time.

Oxford researchers join Novo, Gates, and Wellcome to tackle antimicrobial resistance

Oxford licenses Rift Valley fever vaccine candidate amid West Africa outbreak

NDM scientists recognised in New Year Honours 2026

Oxford University and Brazil Ministry of Health Sign Letter of Intent to Strengthen Cancer Care Across Brazil

Oxford cancer researchers welcome UK AI for Science Strategy, highlighting the opportunity for national AI-ready cancer data